Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Mitglied/er, Klinik für Knochenmarktransplantation
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
From Entry to Outbreak in a High School Setting : Clinical and Wastewater Surveillance of a Rare SARS-CoV-2 VariantIn: Viruses, Jg. 17, 2025, Nr. 4, 477DOI, Online Volltext (Open Access)
-
Overall Survival in Male Patients With Advanced Hematological Disease (Mostly Acute Leukemia) Is Influenced by CYP1B1 C432G Polymorphism and Donor Sex in Allogeneic Stem Cell TransplantationIn: American Journal of Hematology, Jg. 100, 2025, Nr. 2, S. 323 – 325DOI (Open Access)
-
Lower overall survival in male patients with advanced disease undergoing allogeneic hematopoietic stem cell transplantation is associated with CYP1B1 Leu432Val polymorphismIn: Haematologica / The Hematology Journal, Jg. 109, 2024, Nr. 3, S. 799 – 808DOI (Open Access)
-
T Cell Responses against Orthopoxviruses in HIV-Positive PatientsIn: Vaccines, Jg. 12, 2024, Nr. 2, 131DOI (Open Access)
-
AGIHO guideline on evidence-based management of COVID-19 in cancer patients : 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variantsIn: European Journal of Cancer (EJC), Jg. 181, 2023, S. 102 – 118DOI (Open Access)
-
Long-Term Follow-Up after Adoptive Transfer of BK-Virus-Specific T Cells in Hematopoietic Stem Cell Transplant RecipientsIn: Vaccines, Jg. 11, 2023, Nr. 4, S. 845DOI, Online Volltext (Open Access)
-
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies : 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)In: Journal of Antimicrobial Chemotherapy, Jg. 78, 2023, Nr. 8, S. 1813 – 1826DOI (Open Access)
-
Cellular Immune Response after Vaccination with an Adjuvanted, Recombinant Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant RecipientsIn: Vaccines, Jg. 10, 2022, Nr. 5, 809DOI (Open Access)
-
Cellular and Humoral Immunity after the Third Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplant RecipientsIn: Vaccines, Jg. 10, 2022, Nr. 6, 972DOI, Online Volltext (Open Access)
-
Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatmentIn: Frontiers in Immunology, Jg. 13, 2022, 980698DOI, Online Volltext (Open Access)
-
2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapyIn: European Journal of Cancer (EJC), Jg. 147, 2021, S. 154 – 160DOI (Open Access)
-
A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantationIn: Blood Advances, Jg. 5, 2021, Nr. 6, S. 1760 – 1769DOI (Open Access)
-
Central venous catheter–related infections in hematology and oncology : 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)In: Annals of Hematology, Jg. 100, 2021, Nr. 1, S. 239 – 259DOI (Open Access)
-
Convalescent plasma treatment of critically ill intensive care COVID-19 patientsIn: Transfusion, Jg. 61, 2021, Nr. 5, S. 1394 – 1403DOI (Open Access)
-
Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agent : A retrospective multicenter analysis on behalf of the German Cooperative Transplant Study GroupIn: Annals of Hematology, Jg. 100, 2021, Nr. 8, S. 2141 – 2142DOI (Open Access)
-
Cytomegalovirus kinetics after hematopoietic cell transplantation reveal peak titers with differential impact on mortality, relapse and immune reconstitutionIn: American Journal of Hematology, Jg. 96, 2021, Nr. 4, S. 436 – 445DOI (Open Access)
-
Evaluation of three commercial PCR assays for the detection of azole-resistant Aspergillus fumigatus from respiratory samples of immunocompromised patientsIn: Journal of Fungi, Jg. 7, 2021, Nr. 2, S. 132DOI, Online Volltext (Open Access)
-
Humoral and cellular vaccination responses against sars-cov-2 in hematopoietic stem cell transplant recipientsIn: Vaccines, Jg. 9, 2021, Nr. 10, 1075DOI (Open Access)
-
Long-Term Survival Benefit after Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic LeukemiaIn: Transplantation and Cellular Therapy, Jg. 27, 2021, Nr. 1, S. 95.e1 – 95.e4DOI (Open Access)
-
Pregnancies and neonatal outcomes in patients with sickle cell disease (SCD) : Still a (high-)risk constellation?In: Journal of Personalized Medicine, Jg. 11, 2021, Nr. 9, 870DOI, Online Volltext (Open Access)
-
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents : A retrospective multicenter analysis on behalf of the German Cooperative Transplant Study GroupIn: Annals of Hematology, Jg. 100, 2021, Nr. 4, S. 959 – 968DOI (Open Access)
-
Baseline chest computed tomography as standard of care in high‐risk hematology patientsIn: Journal of Fungi, Jg. 6, 2020, Nr. 1, S. 36DOI (Open Access)
-
Evidence-based management of COVID-19 in cancer patients : Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)In: European Journal of Cancer (EJC), Jg. 140, 2020, S. 86 – 104DOI (Open Access)
-
Optimizing anti-T-lymphocyte globulin dosing to improve long-term outcome after unrelated hematopoietic cell transplantation for hematologic malignanciesIn: American Journal of Transplantation, Jg. 20, 2020, Nr. 3, S. 677 – 688DOI (Open Access)
-
Performance of the AsperGenius® PCR assay for detecting azole resistant Aspergillus fumigatus in BAL fluids from allogeneic HSCT recipients : A prospective cohort study from Essen, West GermanyIn: Medical Mycology, Jg. 58, 2020, Nr. 2, S. 268 – 271
-
Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)In: Mycoses, Jg. 63, 2020, Nr. 7, S. 653 – 682DOI (Open Access)
-
Veno-Venous Extracorporeal Membrane Oxygenation in Adult Patients with Sickle Cell Disease and Acute Chest Syndrome : a Single-Center ExperienceIn: Hemoglobin, Jg. 44, 2020, Nr. 2, S. 71 – 77
-
Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantationIn: Journal of Clinical Oncology (JCO), Jg. 37, 2019, Nr. 5, S. 375 – 385DOI, Online Volltext (Open Access)
-
Adoptive transfer of cellular immunity against cytomegalovirus by virus-specific lymphocytes from a third-party family donorIn: Bone Marrow Transplantation, Jg. 53, 2018, Nr. 10, S. 1351 – 1355
-
Cytomegalovirus induces HLA-class-II-restricted alloreactivity in an acute myeloid leukemia cell lineIn: PLoS ONE, Jg. 13, 2018, Nr. 1, S. e0191482DOI, Online Volltext (Open Access)
-
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies : 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)In: Annals of Hematology, Jg. 97, 2018, Nr. 2, S. 197 – 207DOI (Open Access)
-
Sensitive detection of rare antigen-specific T cells directed against Wilms’ tumor 1 by FluoroSpot assayIn: Leukemia and Lymphoma, Jg. 59, 2018, Nr. 2, S. 490 – 492
-
Clinical utility of quantitative PCR for chimerism and engraftment monitoring after allogeneic stem cell transplantation for hematologic malignanciesIn: Biology of Blood and Marrow Transplantation, Jg. 23, 2017, Nr. 10, S. 1658 – 1668
-
Early CMV replication after allogeneic stem cell transplantation is associated with a reduced relapse risk in acute myeloid leukemia : results of a prospective non-interventional trialIn: Oncology Research and Treatment, Jg. 40, 2017, Nr. Suppl. 3, Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts, S. 101
-
Early CMV-replication after allogeneic stem cell transplantation is associated with a reduced relapse risk in lymphomaIn: Leukemia and Lymphoma, Jg. 58, 2017, Nr. 4, S. 822 – 833
-
αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantationIn: Bone Marrow Transplantation, Jg. 52, 2017, Nr. 12, S. 1668 – 1670DOI (Open Access)
-
CD34+ highly enriched allogeneic stem cell transplantation in a patient with mixed phenotype acute leukemia and Fusarium solani sepsisIn: Annals of Hematology, Jg. 95, 2016, Nr. 1, S. 155 – 156
-
Control of hepatitis B virus infection in hematopoietic stem cell recipients after receiving grafts from vaccinated donorsIn: Bone Marrow Transplantation, Jg. 51, 2016, Nr. 3, S. 428 – 431
-
Cytomegalovirus replication reduces the relapse incidence in patients with acute myeloid leukemiaIn: Blood, Jg. 128, 2016, Nr. 3, S. 456 – 459
-
Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples : results of a prospective multicentre studyIn: Clinical Microbiology and Infection, Jg. 22, 2016, Nr. 10, S. 862 – 868
-
Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-DiseaseIn: Digestive Diseases and Sciences, Jg. 61, 2016, Nr. 7, S. 2019 – 2026
-
Cytomegalovirus induces apoptosis in acute leukemia cells as a virus-versus-leukemia functionIn: Leukemia and Lymphoma, Jg. 56, 2015, Nr. 11, S. 3189 – 3197
-
Methylenetetrahydrofolate reductase polymorphism has no differential effect on the outcome of allogeneic hematopoietic stem cell transplantIn: Leukemia and Lymphoma, Jg. 56, 2015, Nr. 8, S. 2473 – 2475
-
A non-interventional study of the genetic polymorphisms of NOD2 associated with increased mortality in non-alcoholic liver transplant patientsIn: BMC Gastroenterology, Jg. 14, 2014, Nr. 1, S. 4DOI (Open Access)
-
Human chorionic gonadotropin and indolamine 2,3-dioxygenase in patients with GVHDIn: Bone Marrow Transplantation, Jg. 49, 2014, Nr. 6, S. 800 – 805
-
Inhibition of mTOR with everolimus and silencing by vascular endothelial cell growth factor-specific siRNA induces synergistic antitumor activity in multiple myeloma cellsIn: Cancer Gene Therapy, Jg. 21, 2014, Nr. 7, S. 275 – 282
-
Neuromuscular complications after hematopoietic stem cell transplantationIn: Supportive Care in Cancer, Jg. 22, 2014, Nr. 9, S. 2337 – 2341
-
Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cellsIn: Cancer Gene Therapy, Jg. 20, 2013, Nr. 7, S. 421 – 427
-
Bronchiolitis obliterans after allogeneic hematopoietic SCT : Further insight - New perspectives?In: Bone Marrow Transplantation, Jg. 48, 2013, Nr. 9, S. 1224 – 1229
-
Delayed graft-versus-mast-cell effect on systemic mastocytosis with associated clonal haematological non-mast cell lineage disease after allogeneic transplantationIn: Bone Marrow Transplantation, Jg. 48, 2013, Nr. 5, S. 732 – 733
-
Increased susceptibility for aspergillosis and post-transplant immune deficiency in patients with gene variants of TLR4 after stem cell transplantationIn: Transplant Infectious Disease, Jg. 15, 2013, Nr. 5, S. 533 – 539
-
Influence of CEACAM expression in graft-versus-host disease after allogeneic transplantationIn: Bone Marrow Transplantation, Jg. 48, 2013, Nr. Suppl. 2, S. S179 – S180
-
Long-term observation of thrombotic microangiopathies after haematopoietic stem cell transplantationIn: Bone Marrow Transplantation, Jg. 48, 2013, Nr. Suppl. 2, S. 352
-
Maternal molecular features and gene profiling of monocytes during first trimester pregnancyIn: Journal of Reproductive Immunology, Jg. 99, 2013, Nr. 1-2, S. 62 – 68
-
Significantly delayed T-cell immune reconstitution under mycophenolate-containing triple immunosuppressive therapy after allogeneic stem cell transplantationIn: Bone Marrow Transplantation, Jg. 48, 2013, Nr. Suppl. 2, S. S148 – S149
-
Thoughts on feto-maternal tolerance : Is there a lesson to be learned from allogeneic haematopoietic stem cell transplantation?In: Cell Biology International, Jg. 37, 2013, Nr. 8, S. 766 – 767
-
CMV-Replication After Allogeneic Stem Cell Transplantation Is Associated with a Gvhd-Independent Reduced Relapse Risk in LymphomaIn: Blood, Jg. 120, 2012, Nr. 21, S. 1635
-
CMV-replication after allogeneic stem cell transplantation is associated with a GVHD-independent reduced relapse risk in lymphomaIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 156
-
Clinical course and molecular features in 21 patients with atypical chronic myeloid leukemiaIn: International Journal of Laboratory Hematology, Jg. 34, 2012, Nr. 1, S. e3 – e5
-
Different Panel of Gene Variants Influence Outcome of Transplant From Sibling Donors Compared to HLA-Identical Unrelated DonorsIn: Blood, Jg. 120, 2012, Nr. 21, S. 4182
-
Different gene variants are associated with outcome of patients transplanted from HLA-identical unrelated donors compared to patients with sibling donorsIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. S165 – S166
-
Dynamic international prognostic scoring system scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosisIn: Haematologica, the hematology journal, Jg. 97, 2012, Nr. 10, S. 1574 – 1581DOI (Open Access)
-
Improvement in Oral Chronic Graft-versus-Host Disease with the Administration of Effervescent Tablets of Topical Budesonide-An Open, Randomized, Multicenter StudyIn: Biology of Blood and Marrow Transplantation, Jg. 18, 2012, Nr. 1, S. 134 – 140
-
Incidence and outcome of thrombotic microangiopathies after haematopoietic stem cell transplantationIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 197
-
Incidence and outcome of thrombotic microangiopathies after hematopoietic stem cell transplantationIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 211
-
Incidence, mortality and biological characteristics of Bronchiolitis obliterans after allogeneic haematopoietic stem cell transplantationIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 51
-
Incidence, mortality and biological characteristics of bronchiolitis obliterans (BO) after allogeneic haematopoietic stem cell transplantation (HSCT)In: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 199 – 200
-
Influence of CEACAMs expression in graft-versus-host disease after allogeneic transplantationIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 125
-
Influence of Ceacams Expression in Graft-Versus-Host Disease After Allogeneic TransplantationIn: Blood, Jg. 120, 2012, Nr. 21, S. 4490
-
Influence of Micrornas Expression in Graft-Versus-Host Disease After Allogeneic TransplantationIn: Blood, Jg. 120, 2012, Nr. 21
-
Influence of microRNAs expression in graft-versus-host disease after allogeneic transplantationIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 92
-
Jian-Jian Luan Award CMV-replication after allogeneic stem cell transplantation is associated with a GvHD-independent reduced relapse risk in lymphoma : evidence for a putative virus-versus-lymphoma effectIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 60
-
Only gene variants of IL10, IL23R and LCT 13910 influence transplant outcome of patients with HLA-identical unrelated donors as well as patients with sibling donorsIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 127
-
Outcome of allogeneic haematopoietic stem cell transplantation in patients with atypical chronic myeloid leukaemiaIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 428
-
Quantitative expression of Toll-like receptor-1,-2,-3,-5,-7, and-9 in blasts of patients with newly diagnosed or relapsed acute myeloid leukaemiaIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 113
-
Response : T cells are required for the CMV-induced antileukemia effect after transplantIn: Blood, Jg. 119, 2012, Nr. 4, S. 1090 – 1091
-
Significance of prognostic scores, risk factors and chronic graft-versus-host disease on outcome after allogeneic haematopoietic stem cell transplantation for myelofibrosisIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 433
-
T cells are required for the CMV-induced anti-leukemic effect in patients with acute myeloid leukemia patients after transplantIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 173
-
T-cells but not KIR ligand incompatibilities are required for the CMV-induced anti-leukaemic effect in patients with AML after transplantIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 71
-
The effect of low-energy laser therapy on oral chronic graft versus host diseaseIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 210
-
Chronic GvHD is the most pivotal factor for improved relapse-free survival in patients with myelofibrosis after myeloablative allogeneic haematopoietic stem cell transplantationIn: Bone Marrow Transplantation, Jg. 46, 2011, Nr. Suppl. 1, S. S362 – S362
-
Early CMV-replication after allogeneic stem cell transplantation is associated with a dramatically reduced relapse risk in acute myeloid leukemia patients : Evidence for a putative virus-versus-leukemia effectIn: Onkologie, Jg. 34 6, 2011, S. 297 – 297
-
Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk : evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patientsIn: Blood, Jg. 118, 2011, Nr. 5, S. 1402 – 1412DOI (Open Access)
-
GCSF reduces mutated (CD27+) B-cells but increases unmutated naive (CD27-) B-cells in stem cell donorsIn: Bone Marrow Transplantation, Jg. 46, 2011, Nr. Suppl. 1, S. S344 – S345
-
Increased miRNA17 and miRNA20a expression in patients with development of acute graft-versus-host disease after allogeneic stem cell transplantationIn: Bone Marrow Transplantation, Jg. 46, 2011, Nr. Suppl. 1, S. S243 – S244
-
Inhibition of mTOR with everolimus (RAD001) and silencing by vascular endothelial cell growth factor specific siRNA induces additive antitumor activity in multiple myeloma cellsIn: Onkologie, Jg. 34 6, 2011, S. 163 – 163
-
Modulating impact of human chorionic gonadotropin hormone on the maturation and function of hematopoietic cellsIn: Journal of Leukocyte Biology (JLB), Jg. 90, 2011, Nr. 5, S. 1017 – 1026
-
Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donorsIn: Bone Marrow Transplantation, Jg. 46, 2011, Nr. 5, S. 702 – 708DOI (Open Access)
-
Small interfering RNA against BCR-ABL transcripts sensitize mutated T315I cells to nilotinibIn: Haematologica, the hematology journal, Jg. 95, 2010, Nr. 3, S. 388 – 397
-
Allogene Stammzelltransplantation nach COVID19
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,In: Oncology Research and Treatment. Basel: Karger, Jg. 45, 2022, Nr. Supplement 2, S. 191DOI (Open Access) -
CML Relapse after Allogeneic HSCT : Survival, Treatment Efficacy and Prognostic Factors for Outcome
46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) ; 29 August - 1 September, 2020, Virtual Meeting,In: Bone Marrow Transplantation. London: Springer Nature, Jg. 55, 2020, Nr. Suppl. 1, S. 275 – 276DOI (Open Access) -
Cellular immune response after vaccination against varicella zoster virus in hematopoietic stem cell transplantation recipients
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment. Basel: Karger, Jg. 43, 2020, Nr. Suppl. 4, S. 53DOI (Open Access) -
Fertility in Adult Female Allogeneic Stem Cell Recipients
46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) ; 29 August - 1 September, 2020, Virtual Meeting,In: Bone Marrow Transplantation. London: Springer Nature, Jg. 55, 2020, Nr. Suppl. 1, S. 149 – 150DOI (Open Access) -
Impact of Mutation Profile in Chronic Myelomonocytic Leukemia undergoing Allogeneic Hematopoietic Cell Transplantation
46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) ; 29 August - 1 September, 2020, Virtual Meeting,In: Bone Marrow Transplantation. London: Springer Nature, Jg. 55, 2020, Nr. Suppl. 1, S. 570 – 571DOI (Open Access) -
Long-term survival benefit after allogeneic hematopoietic cell transplantation in chronic myelomonocytic leukemia
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment. Basel: Karger, Jg. 43, 2020, Nr. Suppl. 4, S. 170DOI (Open Access) -
Sickle Cell Disease (SCD) : a single-centre experience - update
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment. Basel: Karger, Jg. 43, 2020, Nr. Suppl. 4, S. 180 – 181DOI (Open Access) -
CML relapse after allogeneic HSCT : survival, treatment efficacy and prognostic factors for outcome
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 42, 2019, Nr. Supplement 4: Abstracts, S. 218DOI (Open Access) -
Clinical Relevance of Somatic Mutations in Chronic Myelomonocytic Leukemia Undergoing Allogeneic Stem Cell Transplantation
61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Orlando, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 134, 2019, Nr. Supplement_1: 61st ASH Annual Meeting, S. 1713 – 1713DOI (Open Access) -
Cytomegalovirus reactivation kinetics as predictors of survival and relapse after allogeneic cell transplantation for hematologic malignancies
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 42, 2019, Nr. Supplement 4: Abstracts, S. 203DOI (Open Access) -
Long-term outcome after transplantation in patients with chronic myeloid leukemia from HLA-compatible unrelated donors
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 42, 2019, Nr. Supplement 4: Abstracts, S. 131DOI (Open Access) -
Outcome and reconstitution after allogeneic hematopoietic stem cell transplantation in patients with secondary myelofibrosis : a retrospective cohort study
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 42, 2019, Nr. Supplement 4: Abstracts, S. 283DOI (Open Access) -
Cytomegalovirus induces HLA-class-II-restricted alloreactivity in acute myeloid leukemia cell lines
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 53 – 54DOI (Open Access) -
Gene variants and miRNAs on the prediction of GvHD after allogeneic stem cell transplantation for patients with acute myeloid leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 89DOI (Open Access) -
Impact of anti-Jurkat anti-thymocyte globuline on long-term outcome of Allogeneic matched unrelated donor hematopoietc cell transplantation in hematologic malignancies : A large single-center comparative analysis
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 151DOI (Open Access) -
Long-Term Survival after Transplantation in Patients with Chronic Myeloid Leukemia from HLA-Compatible Unrelated Donors: : May the Stem Cell Source Influence the Outcome?
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 132, 2018, Nr. Supplement 1, S. 5775 – 5775DOI (Open Access) -
MiRNA expression after allogeneic stem cell transplantation
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 89DOI (Open Access) -
New AGIHO-guideline for diagnosis and therapy of CVC-associated infections
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 147DOI (Open Access) -
Performance of the AsperGenius® PCR assay for detecting azole resistance Aspergillus fumigatus in BAL fluids from allogeneic hematological stem cell transplant recipients : A prospective study from Essen, West Germany
52nd Scientific Conference of the German speaking Mycological Society (DMykG) e. V. together with the Austrian Society for Medical Mycology (ÖGMM), 6 September – 8 September 2018, Innsbruck, Austria,In: Mycoses. Hoboken: Wiley-Blackwell - STM, Jg. 61, 2018, Nr. Supplement 1, S. 3DOI (Open Access) -
Stem cell source may influence outcome of transplantation in patients with chronic myeloid leukemia from HLA-compatible unrelated donors
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 118DOI (Open Access) -
The role of donor clonal hematopoiesis in allogeneic hematopoietic stem cell transplantation
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 13DOI (Open Access) -
Mechanistic analysis of CD3-driven T cell functions reveals a CD32a polymorphism associated with melanoma emergenceIn: Experimental Dermatology. Hoboken: Wiley, Jg. 24, 2015, Nr. 3, 42nd Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), March 05-07, 2015, Ulm, Germany, S. E18 – E18
-
Performance of combinations of Aspergillus PCR, multifungal DNA microarray, galactomannan, 1,3-beta-D-glucan and Aspergillus azole resistance PCRs in blood and BAL samples for diagnosis and characterization of invasive fungal infections in haematological
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,In: Oncology Research and Treatment. Basel: Karger, Jg. 38, 2015, Nr. Suppl. 5, S. 190 -
Early CMV-replication after allogeneic stem cell transplantation is associated with a dramatically reduced relapse risk in acute myeloid leukaemia patients : evidence for a putative virus-versus-leukaemia effectIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 46, 2011, Nr. Suppl. 1, S. S56 – S57
-
Early cytomegalovirus replication after allogeneic stem cell transplantation is associated with a dramatically reduced relapse risk in acute myeloid leukemia patients : Evidence for a putative virus-versus-leukemia effectIn: Biology of Blood and Marrow Transplantation: Elsevier Health Sciences, Jg. 17, 2011, Nr. 2, Suppl., S. S161DOI (Open Access)
-
Improved outcome of transplant in patients with CMLIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 46, 2011, Nr. Suppl. 1, S. 361 – 362
-
Increased miRNA17 and miRNA20a expression in patients with development of acute Graft-versus-host disease after allogeneic stem cell transplantation
Deutsche, Österreichische und Schweizerische Gesellschaften für Hämatologie und Onkologie Jahrestagung, Basel, September-Oktober 2011,In: Onkologie. Basel: Karger, Jg. 34, 2011, Nr. Suppl. 6, S. 278 -
Oxidative stress induced by small interfering RNA against glutathione reductase transcripts sensitizes mutated T315l cells to nilotinibIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 46, 2011, Nr. Suppl. 1, S. 365 – 366
-
Pravastatin after allogeneic haematopoietic stem cell transplantation : better tolerated than expected but without significant influence on chronic graft-versus-host diseaseIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 46 1, 2011, Nr. Suppl. 1, S. S111 – S111
-
Results of simultaneous analysis of 48 gene variants reported to have influence on transplant outcomeIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 46, 2011, Nr. Suppl. 1, S. S66 – S67
-
Results of simultaneously performed analysis of 48 gene variants reported to have influence on transplant outcomeIn: Onkologie. Basel: Karger, Jg. 34, 2011, Nr. Suppl. 6, S. 229
-
Significance of prognostic scores, risk factors and chronic graft-versus-host-disease (cGVHD) on outcome after allogeneic haematopoietic stem cell transplantation (HSCT) for myelofibrosisIn: Onkologie. Basel: Karger, Jg. 34, 2011, Nr. Suppl. 6, S. 206 – 206
-
Cytomegalovirus increases incidence of acute GvHD and reduces the relapse risk for acute leukaemia after transplant : there is a virus-versus-leukaemia effect
EBMT (European Group for Blood and Bone Marrow Transplantation) 2010. March 21-14, 2010. Vienna, Austria,In: Bone Marrow Transplantation. London: Springer Nature, Jg. 45, 2010, Nr. Suppl. 2, S. S79 -
Genetic polymorphism of NQO1 is associated with an increased treatment-related mortality in patients undergoing allogeneic transplantationIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 45, 2010, Nr. Suppl. 2, S. S106
-
Improved outcome of transplant in patients with CML
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie. Basel: Karger, Jg. 33, 2010, Nr. Suppl. 6, S. 84 -
Oxidative stress induced by small interfering RNA against glutathione reductase transcripts sensitizes mutated T315I cells to nilotinib
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie. Basel: Karger, Jg. 33, 2010, Nr. Suppl. 6, S. 142 – 143 -
Challenges to the Management of Pulmonary Mycoses in Allogeneic Hematopoietic Stem Cell TransplantationIn: Combating Fungal Infections. Berlin: Springer, 2010, S. 273 – 287
-
Diagnostische und therapeutische Innovationen der allogenen hämatopoetischen StammzelltransplantationDuisburg Essen, 2009
-
From airport to school to hospital : the story of a rare SARS-CoV-2 virus variant importIn: Das Gesundheitswesen. Stuttgart: Thieme, Jg. 86, 2024, Nr. S02, S. S133 – S134
-
A panel of mass spectrometry based serum protein tests for predicting graft-versus-host disease (GvHD) and its severity
106th Annual Meeting of the American Association for Cancer Research (AACR), April 18-22, 2015, Philadelphia, PA, USA,In: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 75, 2015, Nr. 15 Suppl., S. 599